About this trial

This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

Eligibility criteria

Qualifiers

Diagnosis of cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL) OR admitted to receive autologous or allogeneic HSCT for any indication

Expected to be an inpatient for at least 21 days

Aged 12 to 21 years at enrollment.

Inpatient at Children's National or Children's Hospital of Philadelphia (CHOP).

Disqualifiers

Cognitive impairment sufficient to preclude completing questionnaires appropriately

Insufficient knowledge of English or Spanish that would prohibit completing the study instruments

Previous enrollment

Trial design

Treatments tested in this trial

  • Massage therapy
  • Standard of care

Treatment groups

70 Participants
are divided into 2 treatment groups

Locations

2
Children's National Hospital20010, Washington D.C.District of Columbia, United States
Children's Hospital of Philadelphia19104, PhiladelphiaPennsylvania, United States

Sponsors and collaborators

Children's Hospital of Philadelphia

Lead sponsor

Massage Therapy Foundation

Collaborator

Children's National Research Institute

Collaborator